Stacy L. Taylor - 22 Dec 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
SVP and General Counsel
Signature
/s/ Stacy L. Taylor by Eric Billings as attorney-in-fact
Issuer symbol
ADPT
Transactions as of
22 Dec 2021
Net transactions value
-$353,166
Form type
4
Filing time
23 Dec 2021, 20:00:32 UTC
Previous filing
09 Sep 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $66,352 +10,130 +67% $6.55 25,166 22 Dec 2021 Direct F1
transaction ADPT Common Stock Options Exercise $40,622 +5,208 +21% $7.80 30,374 22 Dec 2021 Direct F1
transaction ADPT Common Stock Sale $460,140 -15,338 -50% $30.00 15,036 22 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -10,130 -66% $0.000000 5,313 22 Dec 2021 Common Stock 10,130 $6.55 Direct F1, F2
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -5,208 -23% $0.000000 17,709 22 Dec 2021 Common Stock 5,208 $7.80 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
F2 The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.